Diagnosis and Monitoring of Hepatitis C Virus Infection Using the Cobas® HCV Test for Use on the Cobas® 4800 System.

• Accurate HCV RNA measurements is important for clinical decision-making • SVR, the endpoint of HCV therapy, is defined by undetectable HCV RNA 12 or 24 weeks after the end of therapy • The cobas® HCV Test is sensitive, precise and reproducible • The cobas HCV Test accurately quantifies HCV RNA in patients receiving IFN-free DAA regimens • Overall percentage agreement of SVR for cobas HCV test and Abbott RealTime HCV was 100%